Avant Genomics vs Thermo Fisher Scientific

Avant Genomics vs Thermo Fisher Scientific, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Avant Genomics is on 34/100 and Thermo Fisher Scientific on 78/100.

Avant GenomicsDeveloping an automated platform for liquid biopsy sample preparation.
Try Avant Genomics
Thermo Fisher ScientificGlobal leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.
Try Thermo Fisher Scientific

Where each one leads

Avant Genomics

  • agent readiness: 38/100 against 22/100

Thermo Fisher Scientific

  • our overall score: 78/100 against 34/100
  • funding raised: $5.5B against $3.0M

At a glance

MeasureAvant GenomicsThermo Fisher Scientific
What it isDeveloping an automated platform for liquid biopsy sample preparation.Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.
CategoryBiotechnology, Healthcare, Genomics, DiagnosticsLife Sciences, Analytical Instruments, Laboratory Equipment, Biotechnology
Sells toBusiness modelB2BB2B
OfferingHardwarePlatform
Founded20211956
HeadquartersCharlottesville, USAWaltham, United States
StatusInactiveActive

Size, funding and growth

MeasureAvant GenomicsThermo Fisher Scientific
EmployeesNot published100,104
Total funding$3.0M$5.5B
Latest roundFunding RoundDebt
ValuationNot published$220B
LinkedIn followersNot published2,298,918

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAvant GenomicsThermo Fisher Scientific
StartupHub scoreOur 0-100 rating34/10078/100
Traction32/10060/100
TeamNot published70/100
CommunityNot published15/100
Search visibility15/10036/100
Quality45/10099/100
Agent readinessHow well an AI agent can read and act on the siteF (38/100)F (22/100)
Domain ratingLink authority, 0-100Not published86/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAvant GenomicsThermo Fisher Scientific
FrameworksNot detectedBootstrap

Avant Genomics vs Thermo Fisher Scientific: common questions

Which is better, Avant Genomics or Thermo Fisher Scientific?

On our 0-100 score Thermo Fisher Scientific rates higher (78/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.

How do Avant Genomics and Thermo Fisher Scientific compare on the numbers?

Avant Genomics leads on agent readiness (38/100 against 22/100). Thermo Fisher Scientific leads on our overall score (78/100 against 34/100), funding raised ($5.5B against $3.0M).

Read the full Avant Genomics review and pricing or the Thermo Fisher Scientific review and pricing. You can also browse other Avant Genomics alternatives we track.